GRACE FANTL: Open Payments
NPI 1710461595 · WESTPORT, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,344 in 58 payments from 10 companies in 2025. Trend: 2023 $555 · 2024 $451 · 2025 $1,344
Food & beverage: $1,344
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 18 | $339 |
| Janssen Biotech, Inc. | 12 | $266 |
| LEO Pharma Inc. | 7 | $196 |
| Regeneron Healthcare Solutions, Inc. | 4 | $126 |
| GENZYME CORPORATION | 4 | $107 |
| ABBVIE INC. | 4 | $99 |
| E.R. Squibb & Sons, L.L.C. | 3 | $82 |
| Organon LLC | 3 | $72 |
| Arcutis Biotherapeutics, Inc. | 2 | $35 |
| Lilly USA, LLC | 1 | $23 |
Products named: TREMFYA, DUPIXENT, ADBRY, COSENTYX, Rhapsido, Sotyktu, SKYRIZI, RINVOQ.
Industry payments across MA — which companies pay providers there.
